profile

Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025

– New findings demonstrate a 72% HI-E response rate at Week 16 with meaningful hemoglobin improvement –– Strong activity observed…

4 days ago

69% surge in entrepreneurs signals new era of growth

LinkedIn’s latest research reveals small businesses are entering 2026 with confidenceAuthenticity and brand credibility emerging as key priorities for small…

1 week ago

Fenova uPVC Door & Window Systems Recognized by Forbes India DGEMS as a SELECT 200 Company with Global Business Potential

SOLAPUR, India, Dec. 3, 2025 /PRNewswire/ -- Fenova uPVC Door & Window Systems, a division of Arihant Profile – Extrusion…

1 week ago

The Global Power of Sport: Bank of America Partners with Great Ethiopian Run to Expand Access to Endurance Sports

Beginning in 2026, Partnership Will Elevate Flagship Race's Global Profile and Significantly Expand Access to Running Opportunities for Children ADDIS…

3 weeks ago

OMD NAMED BEST PERFORMING GLOBAL MEDIA NETWORK FOR THE TENTH CONSECUTIVE TIME

New RECMA Diagnostics Report Reveals OMD "Remains More than Ever the Leader" NEW YORK, Nov. 6, 2025 /PRNewswire/ -- In…

1 month ago

C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting

September 20, 2025 11:00 ET  | Source: C4 Therapeutics, Inc. Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response…

3 months ago

Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease

SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering at Day 84 on the 9mg daily oral…

3 months ago

Former Google Exec Outlines the High-Stakes Battle Behind Google Reviews on Maury Blackman’s Great Minds Think Data

Brad Wetherall, former Director for Google Business Profile, details survival tactics for businesses navigating Google's review ecosystem SAN FRANCISCO, Aug.…

4 months ago

Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery

MILAN, July 17, 2025 /PRNewswire/ -- A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination…

5 months ago

Alamar Biosciences, Alzheimer’s Disease Data Initiative, and Gates Ventures Unite in Global Partnership to Advance Translational Research in Alzheimer’s Disease.

Multi-center project will profile over 40,000 samples using ultra-sensitive NULISA™ technology. FREMONT, Calif., June 10, 2025 /PRNewswire/ -- Alamar Biosciences,…

6 months ago